Sopharma AD-Sofia (XBUL:SFA) Net Issuance of Debt : лв44 Mil (TTM As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Sopharma AD-Sofia's net issuance of debt for the three months ended in Jun. 2024 was лв-21 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2024 was лв44 Mil.

Sopharma AD-Sofia Net Issuance of Debt Historical Data

The historical data trend for Sopharma AD-Sofia's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Net Issuance of Debt Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

49.28

-28.03

-10.16

-76.93

67.21

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Issuance of Debt	Get a 7-Day Free Trial															28.12	94.36	-60.87	31.92	-21.45

Sopharma AD-Sofia Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв44 Mil.

Sopharma AD-Sofia Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.

Sopharma AD-Sofia Headlines

No Headlines